Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0333291
Disease: Bleeding ulcer
Bleeding ulcer
0.030 Biomarker disease BEFREE Pharmacologic management: The group recommends that patients with bleeding ulcers with high-risk stigmata who have had successful endoscopic therapy receive high-dose proton-pump inhibitor (PPI) therapy (intravenous loading dose followed by continuous infusion) for 3 days. 31634917 2019
CUI: C0333291
Disease: Bleeding ulcer
Bleeding ulcer
0.030 Biomarker disease BEFREE We hypothesised that a cyclooxygenase-2-selective NSAID plus proton-pump inhibitor is superior to a non-selective NSAID plus proton-pump inhibitor for prevention of recurrent ulcer bleeding in concomitant users of aspirin with previous ulcer bleeding. 28410791 2017
CUI: C0333291
Disease: Bleeding ulcer
Bleeding ulcer
0.030 Biomarker disease BEFREE The studies report conflicting findings about the effect of H. pylori infection on NSAID-related ulcers, and proton-pump inhibitors (PPIs) seem to be superior to eradication only to prevent recurrent ulcer bleeding with LDA. 22486865 2012